HYDROLYSIS OF LEUCINE-ENKEPHALIN AND ITS ASSOCIATION TO THE K562(S) ERYTHROLEUKEMIC CELL-LINE

被引:2
|
作者
URBANI, A [1 ]
BONGIORNO, L [1 ]
MARINI, M [1 ]
ZONA, C [1 ]
RODA, LG [1 ]
机构
[1] CNR, IST MED SPERIMENTALE & BIOTECNOL, COSENZA, ITALY
来源
IMMUNOPHARMACOLOGY | 1994年 / 27卷 / 02期
关键词
HYDROLYSIS; ASSOCIATION; CELL MODEL; ERYTHROLEUKEMIC SUBLINE K562(S);
D O I
10.1016/0162-3109(94)90046-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Hydrolysis of Leu-enkephalin and association to cells of the radioactive label carried by this peptide have been studied on the K562(S) erythroleukaemic cell subline. Data obtained indicate that in the presence of these cells Leu-enkephalin is rapidly hydrolyzed and that the peptide's radioactive label is partially associated to the cells. Both phenomena are characterized by distinctly diphasic kinetics, and are oppositely modified by cells' stimulated erythroid differentiation. In the presence of proteolysis inhibitors, hydrolysis of Leu-enkephalin and association to cells of its radioactive label are reduced. These data, indicating that enkephalin hydrolysis is a prerequisite for the association of the radiolabel to cells, are consistent with those obtained with other cell lines of different origins and with human mononucleate cells. The modifications induced by differentiation of cells on hydrolysis, association and membrane conductance can be interpreted as an indication of extensive modifications of the membrane structures responsible for the mechanisms controlling those phenomena.
引用
收藏
页码:119 / 130
页数:12
相关论文
共 50 条
  • [11] HYDROLYSIS AND ASSOCIATION OF LEUCINE ENKEPHALIN TO LYMPHOMIC AND ERYTHROLEUKEMIC CELL-LINES .2.
    BONGIORNO, L
    URBANI, A
    MARINI, M
    GILARDI, E
    RODA, LG
    INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1992, 14 (04): : 643 - 653
  • [12] HEMOGLOBIN EXPRESSION IN CLONES OF K562 CELL-LINE
    TESTA, U
    VAINCHENKER, W
    BEUZARD, Y
    ROUYERFESSARD, P
    GUERRASIO, A
    TITEUX, M
    LAPOTRE, P
    BOUGUET, J
    BRETONGORIUS, J
    ROSA, J
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1982, 121 (03): : 649 - 655
  • [13] PRESENCE OF ERYTHROCYTIC COMPONENTS IN THE K562 CELL-LINE
    ANDERSSON, LC
    JOKINEN, M
    GAHMBERG, CG
    KLEIN, E
    KLEIN, G
    NILSSON, K
    INTERNATIONAL JOURNAL OF CANCER, 1979, 24 (04) : 514 - 514
  • [14] DIFFERENTIAL MAGE-1 GENE-EXPRESSION IN 2 VARIANTS OF AN ERYTHROLEUKEMIC CELL-LINE (K562)
    SERRANO, A
    GARCIA, A
    ABRIL, E
    GARRIDO, F
    RUIZCABELLO, F
    IMMUNOBIOLOGY, 1995, 194 (4-5) : 449 - 456
  • [15] Molecular mechanisms of complement resistance of the human erythroleukemic cell line K562
    Jurianz, K
    Ziegler, S
    Donin, N
    Fishelson, Z
    Kirschfink, M
    MOLECULAR IMMUNOLOGY, 1999, 36 (4-5) : 316 - 316
  • [16] MECHANISM OF DIFFERENTIATION OF HUMAN ERYTHROLEUKEMIC CELL-LINE K-562 BY HEMIN
    BALIGA, BS
    MANKAD, M
    SHAH, AK
    MANKAD, VN
    CELL PROLIFERATION, 1993, 26 (06) : 519 - 529
  • [17] HYDROLYSIS AND BINDING OF LEUCINE ENKEPHALIN TO LYMPHOMATOUS AND ERYTHROLEUKEMIC CELL-LINES
    ROSCETTI, G
    BONGIORNO, L
    URBANI, A
    MARINI, M
    RODA, LG
    INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1990, 12 (04): : 391 - 396
  • [18] CHARACTERIZATION OF A K562 MULTIDRUG-RESISTANT CELL-LINE
    YANOVICH, S
    HALL, RE
    GEWIRTZ, DA
    CANCER RESEARCH, 1989, 49 (16) : 4499 - 4503
  • [19] ABSENCE OF ERYTHROCYTIC COMPONENTS IN THE ORIGINAL K562 CELL-LINE
    LOZZIO, BB
    LOZZIO, CB
    INTERNATIONAL JOURNAL OF CANCER, 1979, 24 (04) : 513 - 513
  • [20] EFFECTS OF FAGARONINE ON THE HUMAN CELL-LINE K562 CYCLE
    COMOE, L
    CARPENTIER, Y
    DESOIZE, B
    JARDILLIER, JC
    BULLETIN DU CANCER, 1988, 75 (07) : 691 - 691